Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goshi Nishimura

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|May 8, 2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinomaGoshi Nishimura, Takahide Taguchi, Masahiro Takahashi, et al.
Auris, Nasus, Larynx|September 11, 2007
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomographyChoichi Horiuchi, Takahide Taguchi, Takafumi Yoshida, et al.
Nihon Jibiinkoka Gakkai Kaiho|August 28, 2014
[The accuracy of evaluating the response of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma]Goshi Nishimura, Masanori Komatsu, Takahide Taguchi, et al.
Head & Neck|May 15, 2023
Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinomaJun Aoyama, Yusuke Nojima, Daisuke Sano, et al.
Auris, Nasus, Larynx|July 3, 2007
Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomasGoshi Nishimura, Mamoru Tsukuda, Choichi Horiuchi, et al.
International Journal of Clinical Oncology|December 30, 2015
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinomaGoshi Nishimura, Kenichiro Yabuki, Masaharu Hata, et al.
Anticancer Research|April 1, 2009
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservationGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
International Journal of Clinical Oncology|August 15, 2015
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapyGoshi Nishimura, Masanori Komatsu, Masaharu Hata, et al.
The Laryngoscope|September 1, 2016
Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancerKenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Anticancer Research|May 29, 2023
<i>P4HA1</i> Promotes Cell Migration and Colonization in Hypopharyngeal Squamous Cell CarcinomaKaname Sato, Daisuke Sano, Hideaki Takahashi, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|May 8, 2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinomaGoshi Nishimura, Takahide Taguchi, Masahiro Takahashi, et al.
Auris, Nasus, Larynx|September 11, 2007
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomographyChoichi Horiuchi, Takahide Taguchi, Takafumi Yoshida, et al.
Nihon Jibiinkoka Gakkai Kaiho|August 28, 2014
[The accuracy of evaluating the response of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma]Goshi Nishimura, Masanori Komatsu, Takahide Taguchi, et al.
Head & Neck|May 15, 2023
Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinomaJun Aoyama, Yusuke Nojima, Daisuke Sano, et al.
Auris, Nasus, Larynx|July 3, 2007
Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomasGoshi Nishimura, Mamoru Tsukuda, Choichi Horiuchi, et al.
International Journal of Clinical Oncology|December 30, 2015
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinomaGoshi Nishimura, Kenichiro Yabuki, Masaharu Hata, et al.
Anticancer Research|April 1, 2009
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservationGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
International Journal of Clinical Oncology|August 15, 2015
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapyGoshi Nishimura, Masanori Komatsu, Masaharu Hata, et al.
The Laryngoscope|September 1, 2016
Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancerKenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Anticancer Research|May 29, 2023
<i>P4HA1</i> Promotes Cell Migration and Colonization in Hypopharyngeal Squamous Cell CarcinomaKaname Sato, Daisuke Sano, Hideaki Takahashi, et al.
Pageof 7